Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences, Inc. (INBX) is a healthcare company (biotechnology) based in the United States. The share price is $73.42, down 5.46% on the day, which values the company at $1.08B. Price as of 17 Nov 2026, 19:18 UTC, from Yahoo Finance.

Key facts

Share price
$73.42−5.46% today
Market value
$1.08B
Funk Score
17/100
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Inhibrx Biosciences, Inc. in more detail

INBX trades at -8.6× next year's expected earnings, 542.2× sales.

Over the last five fiscal years Inhibrx Biosciences, Inc. has compounded revenue -36.8% a year. Its Funk Score is 17 out of 100 (financial strength 3.0, profitability 0.4, growth 1.8, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold INBX, including Andreas Halvorsen (0.3% of the portfolio).

Superinvestors holding INBX

1 of the investors tracked here report a position in their latest 13F filing.

Inhibrx Biosciences, Inc. (INBX): questions and answers

What is Inhibrx Biosciences, Inc.'s market cap?

Inhibrx Biosciences, Inc. is valued at $1.08B at a share price of $73.42.

How fast is Inhibrx Biosciences, Inc. growing?

Over the last five fiscal years Inhibrx Biosciences, Inc.'s revenue grew -36.8% a year.

Does INBX pay a dividend?

Inhibrx Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own INBX?

In their latest quarterly filings, Andreas Halvorsen (0.3% of the portfolio) hold INBX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Inhibrx Biosciences, Inc. (INBX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/INBX

Underlying data: Yahoo Finance; company filings with the SEC.